110012-78-7 Usage
Molecular structure
The compound has a complex and intricate molecular structure, with a cyclobutanecarboxylic acid backbone and multiple functional groups.
Functional groups
The compound contains several functional groups, including amino, thiazol, tetrazol, and oxoethylidene moieties.
Stereochemistry
The compound has a chiral center at the 2 and 3 positions of the azetidinyl ring, with the (2S,3S) configuration.
Fluorination
The compound has a fluoromethyl group at the 2 position of the azetidinyl ring.
Tetrazol group
The compound contains a 2H-tetrazol-5-yl group, which may contribute to its potential pharmacological properties.
Biochemical properties
Due to its diverse chemical composition, the compound likely exhibits a range of biochemical properties.
Pharmacological properties
The compound may have potential applications in pharmaceutical research or drug development, but further analysis and research are necessary to fully understand its potential uses and effects.
Solubility
The compound's solubility in water or other solvents is not specified, but it may be influenced by its functional groups and stereochemistry.
Stability
The stability of the compound under various conditions, such as temperature, pH, or in the presence of enzymes, is not specified and would require further investigation.
Synthesis
The synthesis of this complex compound would likely involve multiple steps and the use of various reagents and protecting groups to achieve the desired stereochemistry and functional group incorporation.
Purity
The purity of the compound would need to be confirmed through analytical techniques such as mass spectrometry, nuclear magnetic resonance (NMR) spectroscopy, or high-performance liquid chromatography (HPLC).
Biological activity
The compound's potential biological activity, such as its interaction with specific receptors or enzymes, would need to be evaluated through in vitro and in vivo assays.
Toxicity
The toxicity of the compound, including its potential side effects and safety profile, would need to be assessed through appropriate toxicological studies.
Drug development
If the compound demonstrates promising pharmacological properties and acceptable safety, it may be further developed as a potential drug candidate for specific therapeutic applications.
Check Digit Verification of cas no
The CAS Registry Mumber 110012-78-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,1,0,0,1 and 2 respectively; the second part has 2 digits, 7 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 110012-78:
(8*1)+(7*1)+(6*0)+(5*0)+(4*1)+(3*2)+(2*7)+(1*8)=47
47 % 10 = 7
So 110012-78-7 is a valid CAS Registry Number.
